General Statement of Disclosure:
OFFICER, DIRECTOR ETC: HFSA(NONE) RESEARCH/RESEARCH GRANTS: National Institutes of Health(MODEST) OTHER FINANCIAL BENEFIT: Amgen Inc.(MODEST), AHA(MODEST), AstraZeneca Pharmaceuticals(MODEST), National Institutes of Health(MODEST), National Institutes of Health(MODEST), Novartis Corporation(SIGNIFICANT), AHA(SIGNIFICANT), ACI Clinical(SIGNIFICANT), UpToDate(MODEST), National Institutes of Health(NONE), National Institutes of Health(NONE), Sardocor(MODEST)